|
| Monday, September 27, 2021 |
|
|
君联资本物流供应链投资进入收获期 |
| 近年来，物流行业频频迎来重大资本事件，快运、供应链、货运平台、航空物流、自动驾驶等多个领域都迎来上市潮。 more info >> |
|
|
君聯資本物流供應鏈投資進入收穫期 |
| 近年來，物流行業頻頻迎來重大資本事件，快運、供應鏈、貨運平台、航空物流、自動駕駛等多個領域都迎來上市潮。 more info >> |
|
|
Legend Capital is reaping the rewards in its logistics and supply chain investment |
| In recent years, the logistics and supply chain industry has ushered in many important capital events, with a lot of companies went public in fields like express, supply chain, freight platform, aviation logistics and automatic driving. more info >> |
|
| Tuesday, September 14, 2021 |
|
|
Legend Capital Led a New Round of Investment of Etana |
| Legend Capital led a new round of investment of PT Etana Biotechnologies Indonesia (Etana), along with Innovent Biologics, Inc. (Innovent) (HKEX: 01801), and a consortium led by UOB Venture Management (UOBVM). more info >> |
|
| Friday, September 10, 2021 |
|
|
君联资本上半年收获4个MedTech IPO：深耕长线，聚焦创新 |
| 近日，中国专注于肿瘤全病程管理的基因检测公司“和瑞基因”宣布完成人民币近7亿元B1轮融资，获君联资本持续加持，另有招商局资本领投，启明创投持续加持，中金启辰、易方达资本、福建创新投资、建发新兴投资等知名投资机构跟投。 more info >> |
|
|
君聯資本上半年收穫4個MedTech IPO：深耕長線，聚焦創新 |
| 近日，中國專注於腫瘤全病程管理的基因檢測公司“和瑞基因”宣佈完成人民幣近7億元B1輪融資，獲君聯資本持續加持，另有招商局資本領投，啟明創投持續加持，中金啟辰、易方達資本、福建創新投資、建發新興投資等知名投資機構跟投。 more info >> |
|
|
Legend Capital enjoys 4 MedTech IPOs in 1H2021, focusing on long-term and innovation investment |
| Recently, Berry Oncology, a company focusing on genomic testing of cancers in China, announced the completion of a US$99.15 million Series B1 financing round, with Legend Capital's continuous support. more info >> |
|
| Friday, July 30, 2021 |
|
|
君联资本投资生物计算平台百图生科A轮融资 |
| 生物计算平台企业百图生科近日完成上亿美元A轮融资，君联资本参与了此次投资，本轮融资将主要用于技术研发和人才引进。 more info >> |
|
|
君聯資本投資生物計算平台百圖生科A輪融資 |
| 生物計算平台企業百圖生科近日完成上億美元A輪融資，君聯資本參與了此次投資，本輪融資將主要用於技術研發和人才引進。 more info >> |
|
|
Legend Capital invests in Series A funding round of BioMap, a biological computing platform |
| BioMap, a biological computing platform enterprise, has recently completed the Series A funding round worth over a hundred million US dollars, which Legend Capital participated in. The funds will be used to for R&D and talent recruitment. more info >> |
|
|
|
|
